Acta Neuropathologica: CDKN2A/B pure hercose deficiency is associated with early recurrence of meningioma.
-
Last Update: 2020-07-28
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Most advanced meningiomas exhibit highly interfering copy number distributions and are rich in promoter mutationsIn addition, the absence of pure chontoma lesions of the cell cycle protein-dependent kinase inhibitor () gene in meso-transsexual meningioma was also observedThe author investigates the role of condition in the overall prognosis of meningococyna patients and provides clinical follow-up data covering all grades and subtypesThe main content is to evaluate the predictive power of the state in the context of the hierarchical initiatormutation state and methylation-based classificationMethods: Tumor tissue and clinical follow-up data of patients were obtained from the archives of several international cooperation centers and collected in the Department of Neuropathology of Heidelberg University Hospital (Heidelberg, Germany)Methylation analysis of tumors and copy number analysis using () ( ) arraysThe time distribution of postoperative progress (determined by imaging) or recurrence () is estimated by - method and compared to log rank tests between groupsResults: The high prognosis of purifiable deficiency in meningioma may be useful as an independent molecular biomarker for these tumorsOriginal link: Original source: Original content presentation ends To determine whether the login is over.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
